Glofitamab side effects
Glofitumab (Glofitamab) is a new type of immunotherapy used to treat specific types of malignant tumors, such as lymphoma. While this drug has made significant progress in treating cancer, it can also cause a range of side effects. The occurrence of side effects may vary from person to person, but here are some common side effects of gaffetuzumab:
1.Injection site reactions: Grefituzumab is administered by injection, so redness, swelling, pain, or stinging may occur at the injection site. These symptoms are usually temporary, although sometimes medical intervention may be required.
2.Fever: Some patients may experience fever after treatment. This fever may be mild to moderate, but sometimes it may be more severe. Doctors will monitor the patient's temperature and take appropriate measures if necessary.
3.Shivers: Shivers are a common side effect of gaffetuzumab treatment. Patients may experience chills, shivering, or even fever with significant sweating.
4.Nausea and vomiting: Some patients may experience nausea or even vomiting after treatment with gaffetuzumab. This may require antiemetic medications or other symptomatic treatments to relieve it.
5.Headache: Headache is another common side effect and is usually mild to moderate. These headaches may lessen or disappear after treatment ends.
6.Fatigue: Many patients experience fatigue while receiving gaffetuzumab. This fatigue may persist for some time and may even interfere with daily activities.

7.Anemia: Grefituzumab may cause anemia, which is caused by a reduced number or impaired function of red blood cells. Anemia can cause fatigue, shortness of breath, and other symptoms.
8.Leukopenia: Some patients may develop a decrease in white blood cells after treatment, which increases the risk of infection. Doctors usually monitor white blood cell counts and take preventive measures if necessary.
9.Thrombocytopenia: Graftuzumab may also cause a decrease in thrombocytopenia, which may cause bleeding or congestion. Increased risk of bleeding, especially at the injection site.
10.Allergic Reaction: Although less common, gaffetuzumab may cause an allergic reaction, including symptoms such as rash, shortness of breath, and swelling. Anaphylaxis may require immediate discontinuation and appropriate treatment.
11.Neurological symptoms: Some patients may experience neurological symptoms such as dizziness, tremors, insomnia, or anxiety.
12.Gastrointestinal issues: In addition to nausea and vomiting, some patients may experience diarrhea, abdominal pain, or loss of appetite.
13.Abnormal liver function: Treatment with gaffetuzumab may sometimes cause abnormal liver function, such as elevated transaminases. Doctors will monitor the patient's liver function and take necessary measures.
Please note that the above side effects may not necessarily affect every patient, and their severity may vary on an individual basis. Doctors will monitor patients' symptoms closely and take appropriate steps to manage these side effects while on treatment with gaffetuzumab. If you or a loved one is considering or receiving treatment with gaffetuzumab, be sure to discuss the possible risks and benefits in detail with your doctor so you can make an informed decision. Additionally, following your doctor's recommendations and regular follow-up visits are key to ensuring maximum treatment effectiveness and minimal side effects.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)